Motion DNA Corp fka MTDX

[iOwnSomeNVEI]

News! Motion DNA Posts Stock Acquisition Agreement on Company's website
PHOENIX - PRNewswire-FirstCall - June 13
PHOENIX, June 13 /PRNewswire-FirstCall/ -- Motion DNA Corporation (Pink Sheets:MTDX), announced today that it has posted a copy of the Proxy Statement and Stock Acquisition Agreement between the company and Formula 51-2, LLC on their web site. A copy of the document has been sent to the address of record for each shareholder eligible to vote on the acquisition of all of the company's shares by Formula 51-2, LLC.

To review the Agreement simply log on to
http://www.motiondnacorp.com/investor.php.


About Formula 51-2, LLC:

Formula 51-2, LLC is an Arizona investment company. The company was organized under the laws of the state of Arizona on June 6, 2003, by former NFL all-pro football player Jamir Miller. Now retired from professional football where he starred on professional teams in Cleveland and Arizona, Miller has undertaken several business ventures, including a real estate development company and a food processing center, among other business ventures. Formula 51-2's mission is to locate and enhance existing, undervalued businesses through investments, mergers and acquisitions.

About Motion DNA:

Motion DNA Corporation provides diagnostic testing for medical professionals and sports organizations. Motion DNA's biomechanical analyses and detailed reports provide its customers and consumers with solutions for preventing injuries, identifying physical limitations, diagnosing pre-existing injuries related to biomechanics, and improving physical performance levels. For additional information on the company, please visit the company website at www.motiondnacorp.com.

Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications that may arise could prevent the prompt implementation of any strategically significant plan(s) outlined above. The company cautions that these forward-looking statements are further qualified by other factors. The company undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events or otherwise.

For more information on Motion DNA Contact:
Investor Relations
Motion DNA Corporation
15023 N. 73rd Street
Scottsdale, Arizona 85260
1.877.425.7734 toll free
480.425.7734 phone
480.991.7736 fax

Motion DNA Corporation

Web site: http://www.motiondnacorp.com/investor.php/
http://www.motiondnacorp.com/




Copyright © 2005 PRNewswire